Open AccessBiomarker Glycated Hemoglobin (HbA1c) in Diabetes Mellitus Type II
Author(s) -
Jayanthi Bai,
Jayakrishnan
Publication year - 2021
Publication title -
international journal of health sciences and research
Language(s) - English
Resource type - Journals
ISSN - 2249-9571
DOI - 10.52403/ijhsr.20210603
Subject(s) - medicine , glycated hemoglobin , diabetes mellitus , type 2 diabetes mellitus , biomarker , complication , glycated haemoglobin , intensive care medicine , type 2 diabetes , endocrinology , biochemistry , chemistry
Early diagnosis of diabetes is clinically important in reducing health complications worldwide. In this respect HbA1c has become an accurate biomarker for the diagnosis of Diabetes Mellitus (DM) and its complication [1]. In the present study HbA1c measured in subject of age <20,21-30,31-40 yrs and the level found to show high risk for DM in youngsters. Hence counselling at least once a month is warranted. To be most effective to reduce or prevent the prevalence in youngsters the importance of controlling HbA1c and keeping it at low level can be achieved by including in the curriculum right from school ageing. It will reduce the financial burden on state and central government authorities.Key words: HbA1c, Diabetes Mellitus 2.